T. Rowe Price Investment Management, Inc. Argenx Se Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Argenx Se stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,115,486 shares of ARGX stock, worth $922 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
2,115,486
Previous 1,182,121
78.96%
Holding current value
$922 Million
Previous $450 Million
85.21%
% of portfolio
0.51%
Previous 0.29%
Shares
7 transactions
Others Institutions Holding ARGX
# of Institutions
356Shares Held
31.3MCall Options Held
212KPut Options Held
210K-
Price T Rowe Associates Inc Baltimore, MD5.5MShares$2.4 Billion0.27% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.19MShares$1.39 Billion1.93% of portfolio
-
Janus Henderson Group PLC London, X02.22MShares$966 Million0.49% of portfolio
-
Capital World Investors Los Angeles, CA1.86MShares$813 Million0.13% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$540 Million5.88% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $24.1B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...